Aeterna Zentaris Inc. (AEZS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.65-0.02 (-0.54%)
At close: 4:00 PM EDT
People also watch:
KERXCYCCCTICSNSSAGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.67
Prev Close3.67
Bid3.57 x 500
Ask3.75 x 3000
Day's Range3.61 - 3.72
52wk Range2.60 - 15.70
1y Target EstN/A
Market Cap36.28M
P/E Ratio (ttm)-0.74
Beta0.96
Volume64,525
Avg Vol (3m)176,517
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press14 days ago

    Aeterna Zentaris reports 2Q loss

    The Montreal-based company said it had a loss of 71 cents per share. The drug developer posted revenue of $96,000 in the period. In the final minutes of trading on Tuesday, the company's shares hit $3.61. ...

  • Business Wire14 days ago

    Aeterna Zentaris Reports Second Quarter 2016 Financial and Operating Results

    Aeterna Zentaris Inc. , a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health, today reported financial and operating results for the second quarter ended June 30, 2016.

  • Business Wire16 days ago

    Aeterna Zentaris Expands Promotion of APIFINY® into Florida

    Aeterna Zentaris Inc. today announced that it is expanding its promotion of APIFINY®, the only cancer-specific, non-PSA blood test available to assess the risk for the presence of prostate cancer, into the important Florida market pursuant to its exclusive promotional agreement with Armune BioScience, Inc.